209 related articles for article (PubMed ID: 2849604)
1. In-vitro and in-vivo antibacterial activity of fleroxacin, a new fluorinated quinolone.
Aoyama H; Inoue M; Mitsuhashi S
J Antimicrob Chemother; 1988 Oct; 22 Suppl D():99-114. PubMed ID: 2849604
[TBL] [Abstract][Full Text] [Related]
2. In-vitro activity of fleroxacin compared with three other quinolones.
Bremner DA; Dickie AS; Singh KP
J Antimicrob Chemother; 1988 Oct; 22 Suppl D():19-23. PubMed ID: 3144536
[TBL] [Abstract][Full Text] [Related]
3. In-vitro activity of fleroxacin.
Georgopoulos A; Breyer S; Georgopoulos M; Mailer H; Graninger W
J Antimicrob Chemother; 1988 Oct; 22 Suppl D():25-9. PubMed ID: 3144544
[TBL] [Abstract][Full Text] [Related]
4. Comparative in vitro activity of a new quinolone, fleroxacin, against respiratory pathogens from patients with cystic fibrosis.
Akaniro JC; Vidaurre CE; Stutman HR; Marks MI
Antimicrob Agents Chemother; 1990 Oct; 34(10):1880-4. PubMed ID: 2127170
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo antibacterial activity of AM-833, a new quinolone derivative.
Hirai K; Aoyama H; Hosaka M; Oomori Y; Niwata Y; Suzue S; Irikura T
Antimicrob Agents Chemother; 1986 Jun; 29(6):1059-66. PubMed ID: 2942103
[TBL] [Abstract][Full Text] [Related]
6. In vitro studies of fleroxacin (Ro 23-6240), a new trifluorinated quinolone derivative.
Digranes A; Benonisen E; Salveson A; Zahm F
Chemotherapy; 1988; 34(5):401-10. PubMed ID: 3141116
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of fleroxacin (Ro23-6240), a new fluorinated 4-quinolone against isolates from cancer patients.
Rolston K; Ho DH; LeBlanc B; Bodey GP
Chemotherapy; 1988; 34(6):448-54. PubMed ID: 3149568
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo antibacterial activities of AM-1155, a new 6-fluoro-8-methoxy quinolone.
Hosaka M; Yasue T; Fukuda H; Tomizawa H; Aoyama H; Hirai K
Antimicrob Agents Chemother; 1992 Oct; 36(10):2108-17. PubMed ID: 1332587
[TBL] [Abstract][Full Text] [Related]
9. Comparative in-vitro activity of Ro 23-6240, a new trifluorinated quinolone.
Verbist L
J Antimicrob Chemother; 1987 Sep; 20(3):363-72. PubMed ID: 3119552
[TBL] [Abstract][Full Text] [Related]
10. In-vitro susceptibility of staphylococci to fleroxacin in comparison with six other quinolones.
Pohlod DJ; Saravolatz LD; Somerville MM
J Antimicrob Chemother; 1988 Oct; 22 Suppl D():35-41. PubMed ID: 3144547
[TBL] [Abstract][Full Text] [Related]
11. In vitro antimicrobial activity of sparfloxacin (AT-4140, CI-978, PD 131501) compared with numerous other quinolone compounds.
Jones RN; Barrett MS; Erwin ME; Briggs BM; Johnson DM
Diagn Microbiol Infect Dis; 1991; 14(4):319-30. PubMed ID: 1909615
[TBL] [Abstract][Full Text] [Related]
12. Correlation of in vitro activities of the fluoroquinolones to their in vivo efficacies.
Fernandes PB; Swanson RN
Drugs Exp Clin Res; 1988; 14(6):375-8. PubMed ID: 3145851
[TBL] [Abstract][Full Text] [Related]
13. Antibacterial activities of grepafloxacin, ciprofloxacin, ofloxacin and fleroxacin.
Barry AL; Fuchs PC
J Chemother; 1997 Feb; 9(1):9-16. PubMed ID: 9106012
[TBL] [Abstract][Full Text] [Related]
14. A multicenter comparative study of the in vitro activity of fleroxacin and other antimicrobial agents.
Markowitz SM; Williams DS; Hanna CB; Parker JL; Pierce MA; Steele JC
Chemotherapy; 1995; 41(6):477-86. PubMed ID: 8529440
[TBL] [Abstract][Full Text] [Related]
15. Fleroxacin: in-vitro activity worldwide against 20,807 clinical isolates and comparison to ciprofloxacin and norfloxacin.
Paganoni R; Herzog C; Braunsteiner A; Hohl P
J Antimicrob Chemother; 1988 Oct; 22 Suppl D():3-17. PubMed ID: 3144545
[TBL] [Abstract][Full Text] [Related]
16. Effect of method, medium, pH and inoculum on the in-vitro antibacterial activities of fleroxacin and norfloxacin.
Hohl P; Felber AM
J Antimicrob Chemother; 1988 Oct; 22 Suppl D():71-80. PubMed ID: 3144552
[TBL] [Abstract][Full Text] [Related]
17. Antibacterial activity of ofloxacin and its mode of action.
Sato K; Inoue Y; Fujii T; Aoyama H; Mitsuhashi S
Infection; 1986; 14 Suppl 4():S226-30. PubMed ID: 3028966
[TBL] [Abstract][Full Text] [Related]
18. Comparative in vitro activity of RO 23-6240 (fleroxacin), a new 4-quinolone derivative.
Machka K; Braveny I
Eur J Clin Microbiol; 1987 Aug; 6(4):482-5. PubMed ID: 3117538
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo activities of QA-241, a new tricyclic quinolone derivative.
Asahara M; Tsuji A; Goto S; Masuda K; Kiuchi A
Antimicrob Agents Chemother; 1989 Aug; 33(8):1144-52. PubMed ID: 2679369
[TBL] [Abstract][Full Text] [Related]
20. In vivo evaluation of a dual-action antibacterial, Ro 23-9424, compared to cefotaxime and fleroxacin.
Beskid G; Siebelist J; McGarry CM; Cleeland R; Chan K; Keith DD
Chemotherapy; 1990; 36(2):109-16. PubMed ID: 2107064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
